
-
2012
Company Description
Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none.
Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none. Clementia is rapidly developing its first lead product candidate, palovarotene, to treat fibrodysplasia ossificans progressiva (FOP), an ultra-rare and severely disabling disorder, and other diseases.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Founders:
Clarissa Desjardins -
Company Website:
-
Company E-mail:
-
Company Address:
4150 Ste-Catherine Street West, Suite 550Montréal, QCCanada -
CEO:
- Clarissa Desjardins
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits